AVAI News and Press, Avant Technologies Inc.

Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them PR Newswire Issued on behalf of Avaí Bio, Inc. VANCOUVER, BC , March 3, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary — The global cell therapy market is projected to surpas...

2026-03-03 09:00:27 ET Next-generation cellular therapies and regenerative medicine drive exponential expansion New York, NY – March 3, 2026 – Market News Updates News Commentary – The global anti-aging therapy market is gaining serious momentum as peopl...

Avaí Bio and Austrianova Begin Production of Master Cell Bank for Klotho Anti-Aging Therapy Under GMP Standards Canada NewsWire LAS VEGAS , March 3, 2026 /CNW/ -- Avaí Bio, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company developing t...

VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com Market Intelligence Brief -- Gold just printed $5,000. Not as a fever dream on a commodity trader's whiteboard. Not as a Goldman target for 2030. As a Wednesday. Silver is flirting with $82 and the supply defi...

Avant Technologies Completes Rebranding with Name Change to Avaí Bio and Launch of New Website PR Newswire LAS VEGAS , Feb. 11, 2026 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company focused on devel...

Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration Canada NewsWire Issued on behalf of Avant Technologies Inc. VANCOUVER, BC , Jan. 29, 2026 /CNW/ --  USA News Group News Commentary – Global capital is officially r...

2026-01-26 11:42:30 ET VANCOUVER, British Columbia, Jan. 26, 2026 — Equity Insider Market Intelligence Brief – The global market has entered a cycle of defensive hardening. After a decade of aggressive speculation, the defining theme of 2026 is Resilience...

Avant Technologies Evaluating Advanced Cells for Diabetes Therapy at 15th Annual EPITA Symposium Canada NewsWire LAS VEGAS , Jan. 26, 2026 /CNW/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developin...

VANCOUVER, British Columbia, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary – The medical world is shifting as the global market for next-gen treatments heads toward $88.85 billion by 2030 [1] , driven by a surge in funding for high-tech cures for long-term illness....

VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com Market Intelligence Brief – The era of abundance has reached its limit. The speculative fever of the last decade has been replaced by a scramble for the "Choke Point." The physical and digital bottlenec...